7.58
-0.05(-0.66%)
Currency In USD
| Previous Close | 7.63 |
| Open | 7.67 |
| Day High | 7.82 |
| Day Low | 7.51 |
| 52-Week High | 12.73 |
| 52-Week Low | 4.02 |
| Volume | 830,209 |
| Average Volume | 1.29M |
| Market Cap | 404.4M |
| PE | 2.89 |
| EPS | 2.62 |
| Moving Average 50 Days | 7.55 |
| Moving Average 200 Days | 7.43 |
| Change | -0.05 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $230.33 as of September 07, 2025 at a share price of $7.58. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $72.74 as of September 07, 2025 at a share price of $7.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
GlobeNewswire Inc.
Sep 02, 2025 11:40 AM GMT
GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Ad
Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day
GlobeNewswire Inc.
Aug 29, 2025 12:05 PM GMT
Pro Football Hall of Famer and Ready to Rescue campaign spokesperson, Emmitt Smith, and Release Recovery Founder/CEO, Zac Clark, plan to visit several U.S. college campuses to educate on opioid emergency preparednessNew sponsorship of Mobilize Recove
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
GlobeNewswire Inc.
Aug 21, 2025 12:45 PM GMT
GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States,1 Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for Awareness and Facing Fentanyl Now